Recombinant fragment human surfactant protein-D (Trimunocor Ltd)

N/A

Report date: 2024/11/05 16:40:48

Base Information

Drug NameRecombinant fragment human surfactant protein-D (Trimunocor Ltd)
Drug Alias NamerfhSP-D
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPulmonary surfactant-associated protein D stimulants
TargetsPulmonary surfactant-associated protein D
Therapy Area/IndicationsRespiratory Distress Syndrome, NewbornBronchopulmonary DysplasiaLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrimunocor Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College LondonTrimunocor Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, NewbornBronchopulmonary DysplasiaLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A